Babeș-Bolyai University
Cluj-Napoca, Cluj, 400015, Romania
NCT Number: NCT04179526
To investigate the efficacy and mechanisms of change of an Internet-delivered transdiagnostic REBT intervention for adolescents with internalizing problems.
Looking for future studies?
Notify Me12 year–15 year
All sexes
Interventional
Not applicable
Cluj-Napoca, Cluj, 400015, Romania
The main objectives of this study are to evaluate the efficacy and mechanisms of change of an Internet-delivered Rational Emotive Behavior Therapy for adolescents (12-15 years) diagnosed with a principal anxiety or depressive disorder according to DSM-5 criteria. Participants will be randomly allocated to one of the two groups: experimental (REBTonAd) and waitlist control. The intervention is structured in 8 modules and will be delivered over six weeks. Assessments will be conducted at four time points: baseline, post-treatment, 3-month follow-up, and 6-month follow-up.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The protocol is based on Rational Emotive and Behavioral Therapy (REBT; Ellis, 1962, 1994). The program will consist of 8 modules, delivered online over six weeks.
Time frame: Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up
Change in self-reported internalizing problems from baseline to post-treatment, at 6 months post treatment. Higher scores indicate higher levels of internalizing problems.
Time frame: Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up
Change in negative automatic thoughts from baseline. Higher scores indicating higher levels of negative automatic thoughts.
Time frame: Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up
Change in irrational beliefs from baseline. Higher scores indicate higher levels of irrational beliefs.
Time frame: Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up
Change in quality of life from baseline from baseline. Higher scores indicate higher levels of quality of life.
Time frame: Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up
Change in bullying victimization from baseline. Higher scores indicate higher levels of peer victimization.
Time frame: Baseline, 6-month follow-up
Diagnostic interview for anxiety disorders and/or depressive disorders
Time frame: Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up
Change in anxiety subscale from baseline. This subscale contains 20 items, rated on a 4 point Likert scale, with 0 = Never and 3 = Always. The total score is obtained by summing the 20 items, with higher scores indicating higher symptoms of anxiety.
Time frame: Baseline, Immediately after the intervention (an expected average of 6 weeks), 6-month follow-up
Change in depression subscale from baseline. This subscale contains 20 items, rated on a 4 point Likert scale, with 0 = Never and 3 = Always. The total score is obtained by summing the 20 items, with higher scores indicating higher symptoms of depression.
Time frame: Immediately after the intervention (an expected average of 6 weeks)
Satisfaction with the program. Higher scores indicate higher treatment satisfaction
Babes-Bolyai University
Other
The Efficacy and Mechanisms of Change of a Transdiagnostic Internet-delivered REBT Intervention for Adolescents With Internalizing Problems: A Randomized Controlled Trial
Acronym: REBTonAd
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00688818
Anxiety Disorders, Depressive Disorder
Chatham, Ontario, Canada
View Trial DetailsNCT07028216
Agoraphobia, Anxiety Disorders
Washington D.C., District of Columbia, United States
View Trial DetailsNCT05671419
Agoraphobia, Anxiety Disorders
Washington D.C., District of Columbia, United States
View Trial DetailsNCT06724666
Anxiety Disorders, Behavior
Cluj-Napoca, Romania
View Trial Details